Efavirenz Proguanil 493

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 1 dose
400 mg daily
Drug 2
Drug 2 dose
300 mg x 1
Drug 2 effect

Proguanil AUC increased 113%; Cmax increased 47%; Cycloguanil AUC decreased 38%; Cmax decreased 31%

Clinical Effects

Potential decreased antimalarial effects

Management

Consider using alternative agents. If coadministering, dose adjustment not established

Import ID
493